Literature DB >> 25598480

Hepcidin-25 vs. conventional clinical biomarkers in the diagnosis of functional iron deficiency.

Dietmar Enko1, Helga Wagner2, Gernot Kriegshäuser1, Christine Kimbacher1, Robert Stolba1, Elfriede Worf1, Gabriele Halwachs-Baumann1.   

Abstract

OBJECTIVES: As hepcidin-25 is considered as a key regulator of human iron homoeostasis, this study aimed to compare this parameter with conventional biomarkers and diagnostic tools of iron deficiency (ID).
METHODS: In total, 233 hospitalised adult patients, who underwent routine blood testing for ID, were included. All subjects were investigated for hepcidin-25, reticulocyte haemoglobin content (CHr), soluble transferrin receptor (sTfR)/log ferritin ratio (i.e. Thomas plot), sTfR, ferritin, transferrin saturation (TSAT), C-reactive protein (CRP) and for complete blood cell count. Functional ID was defined as a CHr < 28 pg. Separate logistic regression models were calculated with all potential biomarkers to evaluate and compare the predictive performance with respect to functional ID in patients without (CRP ≤ 0.5 mg/dL) and with (CRP > 0.5 mg/dL) acute-phase reaction, respectively.
RESULTS: One hundred seventeen patients with CRP > 0.5 mg/dL showed a distinctly higher hepcidin-25 median value [35.60 (range: 4.27-80.03) ng/mL] as compared to 116 patients with CRP ≤ 0.5 mg/dL [18.55 (range: 3.77-73.01) ng/mL]. With respect to functional ID, sTfR/log ferritin ratio and sTfR were of better positive predictive value (PPV) (sTfR/log ferritin ratio: 58.33% and 70.83%; sTfR: 60.00% and 60.00%) than when compared to hepcidin-25 (PPV: 37.74% and 42.86%) and ferritin (PPV: 27.54% and 46.15%) in both subgroups.
CONCLUSIONS: The sTfR/log ferritin ratio, as well as sTfR, were better predictors of functional ID in patients with and without acute-phase reaction as compared to hepcidin-25 and ferritin.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  diagnostic implication; functional iron deficiency; hepcidin-25

Mesh:

Substances:

Year:  2015        PMID: 25598480     DOI: 10.1111/ejh.12523

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  4 in total

Review 1.  Diagnosis and treatment of anemia in patients with inflammatory bowel disease.

Authors:  Victoria Mücke; Marcus M Mücke; Tim Raine; Dominik Bettenworth
Journal:  Ann Gastroenterol       Date:  2016-09-06

2.  Intrinsic Iron Release Is Associated with Lower Mortality in Patients with Stable Coronary Artery Disease-First Report on the Prospective Relevance of Intrinsic Iron Release.

Authors:  Julia Ruhe; Christoph Waldeyer; Francisco Ojeda; Alev Altay; Renate B Schnabel; Sarina Schäfer; Karl J Lackner; Stefan Blankenberg; Tanja Zeller; Mahir Karakas
Journal:  Biomolecules       Date:  2018-08-09

3.  Evaluation of a commercial liquid-chromatography high-resolution mass-spectrometry method for the determination of hepcidin-25.

Authors:  Dietmar Enko; Sieglinde Zelzer; Günter Fauler; Markus Herrmann
Journal:  Biochem Med (Zagreb)       Date:  2019-04-15       Impact factor: 2.313

4.  Association between Iron Intake and Diabetic Peripheral Neuropathy in Type 2 Diabetes: Significance of Iron Intake and the Ratio between Iron Intake and Polyunsaturated Fatty Acids Intake.

Authors:  Kyuho Kim; YoonJu Song; Tae Jung Oh; Sung Hee Choi; Hak Chul Jang
Journal:  Nutrients       Date:  2020-11-01       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.